Monthly update to the list of new safety and effectiveness reviews for health products
The list of new safety and effectiveness reviews has been updated and now includes safety reviews initiated between July 1 and 31, 2026. The next update is scheduled for October 2026.
Updated guidance on preparing and submitting summary reports for marketed drugs and natural health products: Notice
The current version of Preparing and Submitting Summary Reports for Marketed Drugs and Natural Health Products – Guidance Document for Industry was published on May 23, 2018. An updated guidance for summary reporting will come into effect on October 1, 2026.
Guidance for industry on notifying Health Canada of foreign actions: Notice
The revised guidance clarifies the requirements to notify Health Canada of foreign actions, updates notification forms, and addresses issues that have led to duplicate or unnecessary reporting.
Monthly update to the Canada Vigilance adverse reaction online database
The data presented in the Canada Vigilance Adverse Reaction Online Database has been updated and now includes information received by Health Canada up to August 28, 2026. The next update of data is scheduled for early October 2026.
BORN Webinar: AI at BORN Ontario: From Foundational Methods to the Frontiers of Perinatal Health
Health Product InfoWatch, August 2026
Content: Product monograph update: Tecfidera (dimethyl fumarate); Notice of market authorization with conditions: Ojemda (tovorafenib)